| 1/22 | US=11 / Fisiologia Vickers PS. Cancer. In: Nair M, Peate I. Fundamentals of applied pathophysiology: an essential guide for nursing students. Oxford: John Wiley & Sons, 2009. p. 34-60. ISBN 978-0-470-51795-6. CANCER; TUMOR; ONCOGENE; QUIMIOTERAPIA; CARCINOGENES; RADIOTERAPIA; IMUNOTERAPIA; CARCINOMA; NEOPLASMA; CITOTOXICIDADE; CANCER. BIOLOGIA; CANCER. CAUSAS; CANCER. ESTADIAMENTO; CANCER. SINTOMAS; CANCER. TRATAMENTO; CANCER. PREVENCAO; LEUCEMIA LINFOBLASTICA AGUDA; CANCER DE PULMAO; CANCER DE MAMA |
| 2/22 | US=85 / Biol/Mol Zolnierczyk JD, Blonski JZ, Robak T, Kilianska ZM, Wesierska-Gadek J. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency purine analogs with cyclophosphamide. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 124-31. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CELULAS B LEUCEMIA LINFOCITICA CRONICA; TERAPIA ANTILEUCEMICA; CITOTOXICIDADE; APOPTOSE; APOPTOSE-CELULA; CELULA-CICLO PROTEINAS RELACIONADAS |
| 3/22 | US=85 / Biol/Mol Thomadaki H, Floros KV, Scorilas A. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new menber BCL2L12. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 276-83. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. LEUCEMIA PROMIELOCITICA AGUDA; APOPTOSE; BAX; BCL2; BCL2L12; CASPASE-3; CITOTOXICIDADE; LADDERING DNA; FAS; HL-60; INIBIDOR MITOTICO; MTT; PCR; TAXOL; VINCRISTINA |
| 4/22 | US=85 / Biol/Mol Yosifov DY, Konstatinov SM, Berger MR. Erucylphospho-N,N,N- trimethylpropylammonium shows substantial cytotoxicity in multiple myeloma cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 350-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. MIELOMA MULTIPLO; ERUFOSINE; ALKYLPHOCHOLINES; CITOTOXICIDADE; MORTE CELULAR PROGRAMADA; ATIVACAO DA CASPASE; CLIVAGEM PARP; LIVRE DE CELULAS DO SISTEMA PARA A APOPTOSE |
| 5/22 | US=85 / Biol/Mol Nicola M, Nuccitelli S, Gattia DM, Traversa E, Magrini A, Bergamaschi A, Ghibelli L. Effects of carbon nanotubes on human monocytes. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 600-5. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. |
| 6/22 | US=108 / Câncer Vidal L, Coffey M, de Bono J. Selective tumour cell cytotoxicity by reoviridae - preclinical evidence and clinical trial results. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 139-50. ISBN 978-0-470-01922-1. VIRUS REOVIRIDAE; CITOTOXICIDADE SELETIVA; ESTRUTURA DO REOVIRUS; REPLICACAO DO REOVIRUS; INFECCAO; ATIVIDADE ONCOLITICA; APOPTOSE; CICLO CELULAR |
| 7/22 | US=23-A / Câncer Tabi Z, Man S. Cancer vaccines and immune monitoring (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 129-59. ISBN 978-1-4020-8441-62. CANCER; VACINA; MONITORAMENTO IMUNOLOGICO; VACINA PROFILATICA; HPV; PAPILOMAVIRUS HUMANO; CANCER CERVICAL; HEPATITE B; CANCER DE FIGADO; HEPATITE C; VACINAS TERAPEUTICAS; VACINAS DE CELULAS DENDRITICAS; TRANSFERENCIA DE CELULAS ADOTIVA T; IMUNOESTIMULANTES INESPECIFICOS; MODIFICADORES DA RESPOSTA IMUNE; QUIMIOTERAPIA; RADIOTERAPIA; MONITORAMENTO DE RESPOSTAS IMUNES; ENSAIOS DE PROLIFERACAO; ENSAIOS DE CITOTOXICIDADE; ENSAIOS DE SECRECAO DE CITOCINAS; TETRAMEROS |
| 8/22 | US=23-C / Câncer Mano M, Machiels JP. Chemoradiation for rectal cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 357-73. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; CANCER DE RETAL; CANCER DE RETO; TRATAMENTO; QUIMIOIRRADIACAO; QUIMIOIRRADIACAO PRE-OPERATORIO; QUIMIOIRRADIACAO POS-OPERATORIO; RADIACAO PRE-OPERATORIO; CITOTOXICIDADE; AGENTES BIOLOGICOS; CAPECITABINA; OXALIPLATINA; TERAPIA ALVO |
| 9/22 | US=437 / Tese/FAP Benevides CFL. Avaliação do perfil de expressão de genes modulados por TNF e melfalano em culturas mistas de células endoteliais, células de melanoma e macrófagos. [Evaluation of the expression profile of genes modulated by TNF and melphalan in mixed cultures of endothelial cells, melanoma cells and macrophages]. São Paulo, 2012. 159 p. Tese(Doutorado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2012/CFBenevides/CFBenevides.pdf |
| 10/22 | US=56 / Biol/Mol Lee BW, Olin MR, Johnson GL, Griffin RJ. In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 109-35. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. FLICA; IN VIVO; IN VITRO; APOPTOSE; CASPASE; IMAGEM; DETECCAO; ENSAIO DE CITOTOXICIDADE |
| 11/22 | US=56 / Biol/Mol Niles AL, Moravec RA, Riss TL. Multiplex caspase activity and cytotoxicity assays. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 151-62. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. ATIVIDADE MULTIPLEX DA CASPASE; ENSAIOS DE CITOTOXICIDADE; FLUORESCENCIA; LUMINESCENCIA; CASPASE |
| 12/22 | US=67 / Biol/Mol Borghaei H, Binyamin L, Astsaturov I, Weiner LM. Antibody therapy of cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 371-412. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER. TERAPIA; ANTICORPOS MONOCLONAIS; TERAPIA DE ANTICORPOS; CITOTOXICIDADE CELULAR DEPENDENTE DE ANTICORPO; CITOTOXICIDADE DEPENDENTE DE COMPLEMENTO; IMUNOCONJUGADOS |
| 13/22 | US=37 / Câncer Bussing A. Mistletoe extracts from the anthroposophical point of view. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 197-206. ISBN 978-1-5889-0323-0. EXTRATOS ISTLETOE; ANTROPOSOFIA; CIENCIA ESPIRITUAL; CITOTOXICIDADE; IMUNOMODULACAO; QUALIDADE DE VIDA |
| 14/22 | US=3 / Ginecologia Stanley MA. Immunobiology of papillomaviruses. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 311-9. ISBN 1-904455-04-2. PAPILOMAVIRUS HUMANO; HPV; IMUNOBIOLOGIA; RESPOSTA IMUNE; INFECCAO VIRAL; CITOCINAS; CELULAS NK; RESPOSTA DE CELULAS T; CD4; CITOTOXICIDADE; IMUNOGENETICA |
| 15/22 | US=55 / Biol/Mol Munch-Petersen B, Piskur J. Deoxynucleoside kinases and their potential role in deoxynucleoside cytotoxicity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 53-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. QUINASES DESOXINUCLEOSIDOS; CITOTOXICIDADE; DEOXIRIBONUCLEOSIDEOS; QUINASE; ANALOGOS NUCLEOSIDEOS; QUIMIOTERAPIA |
| 16/22 | US=55 / Biol/Mol Hunsucker SA, Mitchell BS, Spychala J. Nucleotidases and nucleoside analog cytotoxicity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 81-108. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. NUCLEOTIDASES; CITOTOXICIDADE; ANALOGO DE NUCLEOSIDEO; METABOLISMO DE DROGAS; RESISTENCIA AS DROGAS; ANALOGOS NUCLEOSIDEOS; 5-NUCLEOTIDASE |
| 17/22 | US=8 / Quimioterapia Grem JL. 5-fluoropyrimidines. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 125-82. ISBN 978-0-7817-5628-6. 5-FLUOROPIRIMIDINAS; ESTRUTURA CELULAR; FARMACOLOGIA; MECANISMOS DE ACAO; 5-FLUOROURACIL; FARMACOLOGIA CLINICA; ABSORCAO DO 5-FLUOROURACIL; DISTRIBUICAO DO 5-FLUOROURACIL; CITOTOXICIDADE; MODULACAO DE PIRIMIDINAS; ACIDO FOLINICO |
| 18/22 | US=21 / Cab/Pesc Le QT, Giaccia AJ, Brown JM. The role of tumor hypoxia in head and neck cancer radiotherapy. In: Adelstein JD. Squamous cell head and neck cancer: recent clinical progress and prospects for the future. Totowa: Humana Press, 2005. p. 145-63. ISBN 1-58829473-0. HIPOXIA CELULAR. EFEITOS DE RADIACAO; NEOPLASIAS DE CABECA E PESCOCO; RADIOTERAPIA; QUIMIOTERAPIA; CITOTOXICIDADE IMUNOLOGICA |
| 19/22 | US=477 / Tese/FAP De La Roca RLRF. Expressão de iNOS, COX-2, GLUT1, e Nitrotirosina como biomarcadores preditivos da evolução do adenocarcinoma prostático em pacientes com margens positivas pós-prostatectomia radical. [Expression of iNOS, COX-2, GLUT1, and nitrotirosina as predictive biomarkers from progression of prostatic adenocarcinoma in patients with positive surgical margins post-radical prostatectomy]. São Paulo, 2013. 141 p. Tese(Doutorado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2013/RicardoLRFRoca/RicardoLRFRoca.pdf PROSTATECTOMIA; PROGNOSTICO; PROSTATA; ADENOCARCINOMA; MARCADORES BIOLOGICOS |
| 20/22 | US=916 / Tese/FAP Santos GSS. Impacto da obesidade na instabilidade genômica. [Impact of obesity on genomic instability]. São Paulo, 2021. 75 p. Dissertação(Mestrado)-Fundação Antonio Prudente. Disponível em: https://accamargo.phlnet.com.br/MESTRADO/2021/GSSSantos/GSSSantos.pdf
OBESIDADE; INSTABILIDADE GENOMICA; ADENOCARCINOMA; NEOPLASIAS GASTRICAS; PROGNOSTICO |
